4
Changes in Ownership
Arcus Biosciences, Inc. Filed Acc 0001724521-24-000063
Chief Operating Officer sold 58,625 shares at an average $20.09 ($1,177,967)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Jarrett Jennifer · Chief Operating Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-26 | Sale : show line 1 in the form 10b5-1 | −24,555 | $20.07 | $492,819 | 274,323 | D |
| 2024-02-27 | Sale : show line 2 in the form 10b5-1 | −34,070 | $20.11 | $685,148 | 240,253 | D |
| Open-market sales · 58,625 sh · avg $20.09 · $1,177,967 | ||||||
Loading xslF345X05/wk-form4_1709168145.xml…